Erratum: Impact of transdermal oxybutynin on work productivity in patients with overactive bladder: Results from the MATRIX study (Pharmacoeconomics (2009) 27:4 (329-39)

Laura Pizzi, A. Talati, E. Gemmen, N. V. Dahl, T. J. Bunz, P. K. Sand

Research output: Contribution to journalComment/debate

Original languageEnglish (US)
Pages (from-to)534-535
Number of pages2
JournalPharmacoEconomics
Volume30
Issue number6
DOIs
Publication statusPublished - May 21 2012

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Health Policy
  • Public Health, Environmental and Occupational Health

Keywords

  • Cost-analysis
  • Errata
  • Overactive-bladder treatment
  • Oxybutynin therapeutic use
  • Productivity-costs
  • Workplace

Cite this